Comparing CONMED (CNMD) & Its Competitors

CONMED (NYSE:CNMD) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its peers? We will compare CONMED to similar companies based on the strength of its institutional ownership, profitability, valuation, dividends, analyst recommendations, earnings and risk.

Insider and Institutional Ownership

40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 0.3% of CONMED shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk and Volatility

CONMED has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, CONMED’s peers have a beta of 2.57, suggesting that their average share price is 157% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings for CONMED and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	1	7	0	0	1.88
CONMED Competitors	4295	10588	18372	832	2.46

CONMED presently has a consensus target price of $44.00, indicating a potential downside of 13.09%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.26%. Given CONMED’s peers stronger consensus rating and higher possible upside, analysts plainly believe CONMED has less favorable growth aspects than its peers.

Profitability

This table compares CONMED and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CONMED	5.36%	13.93%	6.26%
CONMED Competitors	-303.57%	-175.14%	-22.20%

Earnings & Valuation

This table compares CONMED and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
CONMED	$1.37 billion	$47.06 million	20.92
CONMED Competitors	$1.87 billion	$137.20 million	5.93

CONMED’s peers have higher revenue and earnings than CONMED. CONMED is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Summary

CONMED peers beat CONMED on 9 of the 13 factors compared.

About CONMED

CONMED Corporation is a medical technology company that develops and markets devices and equipment for orthopedic and general surgery. Its products support minimally invasive procedures and include arthroscopy systems, powered surgical instruments, electrosurgical equipment, and endoscopic technologies. The company was founded in 1970 and serves hospitals, surgery centers, and other healthcare providers. Its products are sold in the United States and internationally.